Sol-Gel Technologies(SLGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SLGL Sol-Gel Technologies

Post-Mkt 12-11 18:49:49 EST

42.30

+0.00

0.00%

盘后40.90

-1.40-3.31%

16:10 EST

High44.00	Low39.05	Vol10.18K
Open44.00	D1 Closing42.30	Amplitude11.70%
Mkt Cap117.84M	Tradable Cap29.16M	Total Shares2.79M
T/O431.03K	T/O Rate1.48%	Tradable Shares689.35K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SLGL","market":"US","secType":"STK","nameCN":"Sol-Gel Technologies","latestPrice":42.3,"timestamp":1765486800000,"preClose":42.3,"halted":0,"volume":10182,"hourTrading":{"tag":"盘后","latestPrice":40.9,"preClose":42.3,"latestTime":"16:10 EST","volume":2,"amount":81.8,"timestamp":1765487404364},"delay":0,"floatShares":689345,"shares":2785787,"eps":-3.225688,"marketStatus":"Post-Mkt","change":0,"latestTime":"12-11 18:49:49 EST","open":44,"high":44,"low":39.05,"amount":431031.6008,"amplitude":0.117021,"askPrice":45,"askSize":107,"bidPrice":40,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-3.225688,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1765501200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1517461200000,"exchange":"NASDAQ","adjPreClose":42.3,"postHourTrading":{"tag":"盘后","latestPrice":40.9,"preClose":42.3,"latestTime":"16:10 EST","volume":2,"amount":81.8,"timestamp":1765487404364},"volumeRatio":0.803796,"impliedVol":1.504,"impliedVolPercentile":0.9485},"requestUrl":"/m/hq/s/SLGL/tweets","defaultTab":"tweets","newsList":[{"id":"2590321772","title":"Opaleye Management Acquires Common Shares of Sol Gel Technologies Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2590321772","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590321772?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:12","pubTimestamp":1765314762,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a beneficial owner, has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 09, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL9WbbN3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Acquires Common Shares of Sol Gel Technologies Ltd","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2588271310","title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588271310","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588271310?lang=en_us&edition=fundamental","pubTime":"2025-12-04 06:39","pubTimestamp":1764801572,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a beneficial owner, has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL91K9dy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2586260131","title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586260131","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586260131?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:06","pubTimestamp":1764191174,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., a beneficial owner, reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL9s6tjK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2585125279","title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2585125279","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585125279?lang=en_us&edition=fundamental","pubTime":"2025-11-22 05:06","pubTimestamp":1763759191,"startTime":"0","endTime":"0","summary":"Opaleye Management Inc., as a beneficial owner, has reported the acquisition of common shares of Sol Gel Technologies Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 21, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDL5zwYjf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Opaleye Management Inc. Reports Acquisition of Sol-Gel Technologies Ltd. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2584394137","title":"Sol-Gel Technologies Announces Q3 2025 Financial Results and Strategic Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2584394137","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584394137?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:54","pubTimestamp":1763646864,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies ( ($SLGL) ) just unveiled an announcement. On November 20, 2025, Sol-Gel Technologies announced its financial results for the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sol-gel-technologies-announces-q3-2025-financial-results-and-strategic-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sol-gel-technologies-announces-q3-2025-financial-results-and-strategic-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2584613465","title":"BRIEF-Sol Gel Technologies Ltd Phase 3 Trial Of Sgt-610 For Gorlin Syndrome Is Ongoing,Top-Line Results Expected Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2584613465","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584613465?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:14","pubTimestamp":1763644477,"startTime":"0","endTime":"0","summary":"BRIEF-Sol Gel Technologies Ltd Phase 3 Trial Of Sgt-610 For Gorlin Syndrome Is Ongoing,Top-Line Results Expected Q4 2026Sol Gel Technologies Ltd SLGL.O:SOL GEL TECHNOLOGIES LTD: PHASE 3 TRIAL OF SGT-6","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nFWN3WW0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2584390301","title":"Sol-Gel Technologies reports Q3 EPS ($2.13) vs (13c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2584390301","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584390301?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:36","pubTimestamp":1763642161,"startTime":"0","endTime":"0","summary":"Reports Q3 revenue $400k vs $5.4M last year. Mori Arkin, Executive Chairman of Sol-Gel, stated: “Sol-Gel continued to make steady progress in the t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sol-gel-technologies-reports-q3-eps-2-13-vs-13c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sol-gel-technologies-reports-q3-eps-2-13-vs-13c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLGL"],"gpt_icon":0},{"id":"2584139400","title":"Sol Gel Technologies Ltd: Expects Its Cash Resources to Fund Cash Requirements Into Q1 of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2584139400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584139400?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:34","pubTimestamp":1763642094,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nFWN3WW0VV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2584139401","title":"Sol-Gel Technologies Q3 EPS $(2.13) Misses $(2.09) Estimate, Sales $400.000K Beat $300.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2584139401","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584139401?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:34","pubTimestamp":1763642056,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly losses of $(2.13) per share which missed the analyst consensus estimate of $(2.09) by 1.91 percent. This is a 1538.46 percent decrease over losses of $(0.13) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48972077/sol-gel-technologies-q3-eps-2-13-misses-2-09-estimate-sales-400-000k-beat-300-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL"],"gpt_icon":0},{"id":"2584139148","title":"Press Release: Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2584139148","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584139148?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:30","pubTimestamp":1763641800,"startTime":"0","endTime":"0","summary":"-- Sol-Gel intends to pursue high-frequency BCC as an additional indication. for its lead drug candidate SGT-610, which, if approved, could at least. -- In September 2025, Sol-Gel announced Health Canada approval of EPSOLAY. -- Sol-Gel signed an additional agreement with Viatris covering Australia. NESS ZIONA, Israel, Nov. 20, 2025  -- Sol-Gel Technologies, Ltd. , a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today announced financial results for the third quarter ending September 30, 2025, and provided a corporate update.-- Sol-Gel's ongoing Phase 3 clinical trial of SGT-610 . for Gorlin syndrome, for which top-line results are expected in the. fourth quarter of 2026, has led to growing physician interest in its. potential use in patients with severe, high-frequency basal cell. devastating form of high-frequency BCC, was found to have a lesion. harboring a PTCH-1 mutation, and Sol-Gel agreed to provide SGT-610 for. compassionate use. S","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCC","AVAX.USD.HKCC","BK4583","BK4007","SOL.USD.HKCC","BK4588","LU1839511570.USD","BK4567","BK4585","LU2087621335.USD","VTRS","BK4104","SLGL"],"gpt_icon":0},{"id":"2584748066","title":"Sol Gel Technologies Ltd. Reports Opaleye Management Inc. as 10% Owner in Initial Ownership Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584748066","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584748066?lang=en_us&edition=fundamental","pubTime":"2025-11-18 05:15","pubTimestamp":1763414152,"startTime":"0","endTime":"0","summary":"Sol Gel Technologies Ltd. has filed an initial statement of beneficial ownership, naming Opaleye Management Inc. as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL6VpXmH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2583577207","title":"Sol Gel Technologies Ltd. held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2583577207","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583577207?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:09","pubTimestamp":1763118556,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies Ltd. held its Annual Meeting of Shareholders on November 11, 2025. Shareholders approved the appointment of Kesselman & Kesselman as independent auditors for 2025. The re-election of Moshe Arkin, Itai Arkin, Hanna Lerman, and Sharon Kochan to the Board of Directors was also approved. In addition, the re-appointment of Moshe Arkin as interim Chief Executive Officer for an additional term effective January 1, 2026, was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 14, 2025, and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL6KF1pG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2582387704","title":"Sol-Gel Technologies Insiders Up US$2.8m On US$867.1k Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2582387704","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582387704?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:05","pubTimestamp":1762783505,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies Ltd. ( NASDAQ:SLGL ) insiders who acquired shares over the previous 12 months, can probably afford...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-slgl/sol-gel-technologies/news/sol-gel-technologies-insiders-up-us28m-on-us8671k-investment","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-slgl/sol-gel-technologies/news/sol-gel-technologies-insiders-up-us28m-on-us8671k-investment","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2578610259","title":"Sol-Gel Technologies Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2578610259","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578610259?lang=en_us&edition=fundamental","pubTime":"2025-10-27 19:12","pubTimestamp":1761563520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SLGL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 27, 2025 07:12 ET (11:12 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVAX.USD.HKCC","SOL.USD.HKCC","SLGL"],"gpt_icon":0},{"id":"2578614995","title":"Sol-Gel Technologies Ltd. : H.c. Wainwright Raises Target Price to $50 From $6","url":"https://stock-news.laohu8.com/highlight/detail?id=2578614995","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578614995?lang=en_us&edition=fundamental","pubTime":"2025-10-27 18:13","pubTimestamp":1761559990,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nAZN4PLMKY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2570043106","title":"Sol-Gel Technologies Announces 2025 Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2570043106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570043106?lang=en_us&edition=fundamental","pubTime":"2025-09-26 02:27","pubTimestamp":1758824851,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies ( ($SLGL) ) has issued an update. Sol-Gel Technologies Ltd. has announced its upcoming 2025 annual general meeting scheduled f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sol-gel-technologies-announces-2025-annual-general-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sol-gel-technologies-announces-2025-annual-general-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLGL","BK4007"],"gpt_icon":0},{"id":"2570048751","title":"Sol-Gel Technologies Ltd. Announces Date for Upcoming Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2570048751","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570048751?lang=en_us&edition=fundamental","pubTime":"2025-09-26 02:13","pubTimestamp":1758824027,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies Ltd. has announced that it will hold its Annual Meeting of Shareholders on November 11, 2025. The meeting will take place at the offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. in New York, NY. Shareholders will have the opportunity to vote on various proposals put forward by the Board of Directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 25, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nNDL6VfDVg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SLGL"],"gpt_icon":0},{"id":"2564376156","title":"Sol-Gel Technologies Ltd. Secures Health Canada Approval for EPSOLAY to Treat Rosacea in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2564376156","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564376156?lang=en_us&edition=fundamental","pubTime":"2025-09-04 19:02","pubTimestamp":1756983768,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies Ltd. has announced that Health Canada has granted regulatory approval for EPSOLAY, a treatment for inflammatory lesions of rosacea in adults. This approval was secured through Sol-Gel's partnership with Searchlight Pharma, which holds exclusive licensing rights for the commercialization of EPSOLAY in Canada. The Notice of Compliance was issued on August 27, 2025, enabling the launch of this innovative treatment for rosacea patients in the Canadian market. The approval is part of a broader strategy by Sol-Gel to commercialize EPSOLAY and TWYNEO across various global territories, with anticipated launches in Europe, Asia, Africa, Latin America, and Australia expected to begin in 2027 and 2028.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDL5fLzPk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL"],"gpt_icon":0},{"id":"2564376080","title":"Sol-Gel Announces Health Canada Approval of EPSOLAY®","url":"https://stock-news.laohu8.com/highlight/detail?id=2564376080","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564376080?lang=en_us&edition=fundamental","pubTime":"2025-09-04 19:00","pubTimestamp":1756983600,"startTime":"0","endTime":"0","summary":"NESS ZIONA, Israel, Sept.  04, 2025  (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd.(NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with severe skin conditions, conducting a P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/04/3144352/0/en/Sol-Gel-Announces-Health-Canada-Approval-of-EPSOLAY.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4603","LU2264538146.SGD","NOC","BK4532","BK4585","LU1064131342.USD","LU1988902786.USD","BK4187","BK4564","SLGL","BK4588","BK4516","BK4007"],"gpt_icon":0},{"id":"2559691936","title":"Sol-Gel Technologies Q2 EPS $4.17 Beats $(0.07) Estimate, Sales $17.261M Beat $2.900M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559691936","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559691936?lang=en_us&edition=fundamental","pubTime":"2025-08-15 19:16","pubTimestamp":1755256582,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly earnings of $4.17 per share which beat the analyst consensus estimate of $(0.07) by 6057.14 percent. This is a 495.71 percent increase over earnings of $0.70 per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47151108/sol-gel-technologies-q2-eps-4-17-beats-0-07-estimate-sales-17-261m-beat-2-900m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLGL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sol-gel.com","stockEarnings":[{"period":"1week","weight":0.0633},{"period":"1month","weight":0.3043},{"period":"3month","weight":0.7566},{"period":"6month","weight":4.625},{"period":"1year","weight":7.2941},{"period":"ytd","weight":3.5479}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.015608},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.077333},{"month":3,"riseRate":0.25,"avgChangeRate":-0.056039},{"month":4,"riseRate":0.375,"avgChangeRate":0.000899},{"month":5,"riseRate":0.5,"avgChangeRate":0.013217},{"month":6,"riseRate":0.625,"avgChangeRate":-0.011897},{"month":7,"riseRate":0.5,"avgChangeRate":0.06768},{"month":8,"riseRate":0.5,"avgChangeRate":0.113954},{"month":9,"riseRate":0.5,"avgChangeRate":-0.011791},{"month":10,"riseRate":0.25,"avgChangeRate":-0.064677},{"month":11,"riseRate":0.625,"avgChangeRate":0.040189},{"month":12,"riseRate":0.375,"avgChangeRate":0.188378}],"exchange":"NASDAQ","name":"Sol-Gel Technologies","nameEN":"Sol-Gel Technologies"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sol-Gel Technologies(SLGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Sol-Gel Technologies(SLGL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Sol-Gel Technologies,SLGL,Sol-Gel Technologies股票,Sol-Gel Technologies股票老虎,Sol-Gel Technologies股票老虎国际,Sol-Gel Technologies行情,Sol-Gel Technologies股票行情,Sol-Gel Technologies股价,Sol-Gel Technologies股市,Sol-Gel Technologies股票价格,Sol-Gel Technologies股票交易,Sol-Gel Technologies股票购买,Sol-Gel Technologies股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sol-Gel Technologies(SLGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Sol-Gel Technologies(SLGL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction